Cross-Reactive Antibody to Swine Influenza A(H3N2) Subtype Virus in Children and Adults Before and After Immunisation With 2010/11 Trivalent Inactivated Influenza Vaccine in Canada, August to November 2010

Eurosurveillance - France
doi 10.2807/ese.17.04.20066-en
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Centre for Disease Control and Prevention (ECDC)

Related search

Immunogenicity and Cross-Reactivity of 2009–2010 Inactivated Seasonal Influenza Vaccine in US Adults and Elderly

PLoS ONE
Multidisciplinary
2011English

Trivalent Inactivated Influenza Vaccine Effective Against Influenza A(H3N2) Variant Viruses in Children During the 2014/15 Season, Japan

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2016English

538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Shedding of Live Vaccine Virus, Comparative Safety, and Influenza-Specific Antibody Responses After Administration of Live Attenuated and Inactivated Trivalent Influenza Vaccines to HIV-infected Children

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2008English

Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children With Recurrent Wheezing

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2013English

Trivalent Inactivated Influenza Vaccine Is Not Associated With Sickle Cell Crises in Children

Pediatrics
Child HealthPediatricsPerinatology
2011English

Differences in Nasal IgA Responses to Influenza Vaccine Strains After Live Attenuated Influenza Vaccine (LAIV) Immunisation in Children

Clinical and Experimental Immunology
AllergyImmunology
2019English

Discordance Between Antibody and T Cell Responses in Recipients of Trivalent Inactivated Influenza Vaccine

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2008English

Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink

Archives of Pediatrics & Adolescent Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy